My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 5 results for

GO
Search Filters: Utah cancel Rhode Island cancel Maine cancel Maryland cancel

Domestic Holiday Travel Pandemic Restrictions and Recommendations

Blog,
Health Policy Update,
Infectious Disease,
COVID-19,
COVID and Community Mitigation,
COVID and Law/Policy,
COVID Preparedness,
Health Equity,
Tribal Health,
Preparedness,
Emergency Powers,
Policy,
State Health Policy,
Territories and Freely Associated States,
Alabama,
Alaska,
American Samoa,
Arizona,
Arkansas,
California,
Colorado,
Connecticut,
Delaware,
Washington, D.C.,
Federated States of Micronesia,
Florida,
Georgia,
Guam,
Hawaii,
Idaho,
Illinois,
Indiana,
Iowa,
Kansas,
Kentucky,
Louisiana,
Maine,
Marshall Islands,
Maryland,
Massachusetts,
Michigan,
Minnesota,
Mississippi,
Missouri,
Montana,
Nebraska,
Nevada,
New Hampshire,
New Jersey,
New Mexico,
New York,
North Carolina,
North Dakota,
Northern Mariana Islands,
Ohio,
Oklahoma,
Oregon,
Palau,
Pennsylvania,
Puerto Rico,
Rhode Island,
South Carolina,
South Dakota,
Tennessee,
Texas,
Utah,
Vermont,
Virgin Islands,
Virginia,
Washington,
West Virginia,
Wisconsin,
Wyoming,
Maggie Davis

The 2020 holiday season is coinciding with a nationwide surge of COVID-19 cases. With great concern that holiday travel to see loved ones may exacerbate community spread of the virus, many states are increasing public health measures ...

Modernizing Public Health Data and Protecting Privacy

Legislative Prospectus,
Data Modernization,
Data Modernization and Informatics,
LGBTQ+,
Population Health and Prevention,
Women, Infant, and Family Health,
Women, Infant, Family Health Data Integration,
Public Health Infrastructure and Systems Improvement,
Public Health Infrastructure and Systems Improvement,
Colorado,
Illinois,
Kentucky,
Maine,
Maryland,
Minnesota,
Nebraska,
New Hampshire,
New Jersey,
Oklahoma,
Rhode Island,
Utah,
Wisconsin

ASTHO Legislative Prospectus | Previewing 2025 state legislative actions on data modernization and privacy.

ASTHO's 2024 Legislative Session Update: Part Two

Blog,
Health Policy Update,
Policy,
State Health Policy,
Public Health Law,
Population Health and Prevention,
Social and Behavioral Health,
Tobacco Control,
Environmental Health,
Public Health Workforce,
Mental Health,
Hawaii,
Utah,
Virginia,
Rhode Island,
Massachusetts,
Maine,
Washington,
Minnesota,
Missouri,
New York,
Maryland,
Connecticut,
Alabama,
New Jersey,
Beth Giambrone,
Maggie Davis,
Christina Severin

ASTHO's 2024 Legislative Session Update: Part Two Beth Giambrone, Maggie Davis, Christina Severin ASTHO's Public Health Legislative Update on Tobacco, Mental Health, Environmental Health, Workforce, and Containing Infectious ...

Expanding Pharmacist-Prescribed HIV PrEP

Brief,
Population Health and Prevention,
Social and Behavioral Health,
STIs,
HIV,
Healthcare Access,
Infectious Disease,
Health Equity,
Race and Public Health,
LGBTQ+,
Arkansas,
California,
Colorado,
Illinois,
Maryland,
Maine,
Massachusetts,
Minnesota,
Missouri,
Nevada,
New Jersey,
New Mexico,
Oregon,
Rhode Island,
Utah,
Virginia,
Rachel Scheckman

PrEP is a powerful tool to reduce new HIV infections; expanding access to PrEP is a priority within the federal Ending the HIV Epidemic in the U.S. initiative. One way to increase access to PrEP is by allowing pharmacists to prescribe and ...

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...